PHILADELPHIA – New preliminary objections have been lodged in complex litigation related to claims over discontinued heartburn fighter and stomach acid suppressant drug Zantac, charging that the plaintiffs’ case is unsound, unsupported and jurisdictionally improper.
PHILADELPHIA – A Philadelphia judge has approved the creation of a qualified settlement fund for one medical device company named as a defendant in complex litigation related to damage for inferior vena cava filters, with Texas-based companies set to supervise the funds.